Session » (0522–0553) Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I
- 10:30AM-12:30PM
-
Abstract Number: 0529
Anti-PeptidylArginine Deiminase-2 (anti-PAD2) Autoantibodies in Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0528
Apolipoprotein A1 and B Levels Indicate Specific Lipid Changes In Early Treatment Naïve Psoriatic Arthritis and Correlate With 1-year Disease Activity
- 10:30AM-12:30PM
-
Abstract Number: 0548
Artificial Intelligence in Axial Spondyloarthritis Diagnosis: Integrating Structural and Inflammatory Lesionsfrom Sacrum MRI
- 10:30AM-12:30PM
-
Abstract Number: 0536
Can achieving sustained low disease activity through treat-to-target management arrest enthesiophyte progression in psoriatic arthritis? A two-year prospective study using high resolution peripheral quantitative computed tomography
- 10:30AM-12:30PM
-
Abstract Number: 0550
Clinical and Genetic Factors Associated with Anti-TNF Therapy Initiation in Radiographic Axial Spondyloarthritis: A 15-Year Observational Study
- 10:30AM-12:30PM
-
Abstract Number: 0535
Comparing Perspectives of Physician-Assessed and Self-Reported Inflammatory Back Pain: Insights from the SHERPAS Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0525
Cost-of-Illness Among Newly Diagnosed Patients with Psoriatic Arthritis in Sweden
- 10:30AM-12:30PM
-
Abstract Number: 0547
Determinants of Difficult-to-Manage Axial Spondyloarthritis: Results from a Prospective Cohort Study
- 10:30AM-12:30PM
-
Abstract Number: 0538
Development of an Artificial Intelligence Tool for Lesion Detection in Axial Spondyloarthritis patients with Active Sacroiliitis on Magnetic Resonance Imaging
- 10:30AM-12:30PM
-
Abstract Number: 0551
Enthesitis Beyond the Surface: Ultrasonographic Unmasking of Preclinical Psoriatic Arthritis in Cutaneous Psoriasis
- 10:30AM-12:30PM
-
Abstract Number: 0530
Evaluating ChatGPT’s Performance in Diagnosing Low Back Pain: A Comparison with Clinicians and Impact of Prompted Specialties
- 10:30AM-12:30PM
-
Abstract Number: 0531
Evaluating the Diagnostic Utility of 14-3-3 eta Autoantibodies in Axial Spondyloarthritis: A Multiplex Assay Approach
- 10:30AM-12:30PM
-
Abstract Number: 0527
Gaps In Documentation Of Psoriatic Arthritis Domains In General Rheumatologic Practices Compared To Rheumatology-Dermatology Combined Clinics
- 10:30AM-12:30PM
-
Abstract Number: 0532
Generative artificial intelligence provides synthetic data to discriminate patients with seronegative rheumatoid arthritis versus psoriatic arthritis sine psoriasis
- 10:30AM-12:30PM
-
Abstract Number: 0549
High Prevalence of Obstructive Sleep Apnea in Psoriatic Arthritis: A Polysomnography-Based Cross-Sectional Study
- 10:30AM-12:30PM
-
Abstract Number: 0537
HLA-B27 and Axial Involvement as Independent Risk Factors for Uveitis in Spondyloarthritis: New Insights from a 15-Year Real-Life Study
- 10:30AM-12:30PM
-
Abstract Number: 0526
Identification of Urine Proteomic Biomarkers Associated with Ankylosing Spondylitis
- 10:30AM-12:30PM
-
Abstract Number: 0541
Inflammatory Back Pain Is Not Associated With HLA-B27 Positivity or CRP Levels in a Nationally Representative U.S. Population
- 10:30AM-12:30PM
-
Abstract Number: 0540
Low-Dose CT reveals syndesmophyte progression in axial SpA, particularly in the thoracic spine: Insights from the SPACE cohort covering early and established disease
- 10:30AM-12:30PM
-
Abstract Number: 0553
Modified A-Tool: An online self-screening tool for axial spondyloarthritis for patients with chronic back pain
- 10:30AM-12:30PM
-
Abstract Number: 0546
Multimorbidity clusters in psoriatic arthritis, psoriasis, and axial spondyloarthritis and their association with healthcare utilization: A population-based study
- 10:30AM-12:30PM
-
Abstract Number: 0544
Prevalence and Baseline Characteristics associated with Difficult-to-Manage Axial Spondyloarthritis in the DESIR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0534
Prevalence and Impact of Fibromyalgia on Disease Outcomes and Treatment in Axial Spondyloarthritis: 10-year Follow-up Data From the DESIR Cohort
- 10:30AM-12:30PM
-
Abstract Number: 0524
Radiographic progression in sacroiliac joints in five years follow up in non-radiographic axial spondyloarthritis patients and the predictive factors
- 10:30AM-12:30PM
-
Abstract Number: 0552
Radiographic Sacroiliitis Progression in Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0533
Reactive Arthritis Transcriptomics: Enriched Enterobacteriaceae-related Pathways in Synovial Fluid and in Blood is Associated with Drug-free Remission
- 10:30AM-12:30PM
-
Abstract Number: 0523
SPECTREM: Guselkumab Significantly Improves Patient Reported Outcomes at Week 16 in Participants with Low Body Surface Area, Moderate Psoriasis with Special Sites Involvement
- 10:30AM-12:30PM
-
Abstract Number: 0545
Temporal trends in the phenotype and treatment outcomes in axial spondyloarthritis patients included in randomized clinical trials over 25 years: a systematic literature review and meta-regression analysis
- 10:30AM-12:30PM
-
Abstract Number: 0522
The Incidence Rate and Risk Factors of Arrhythmias in Patients with Psoriatic Arthritis
- 10:30AM-12:30PM
-
Abstract Number: 0542
Transition from Psoriasis to Psoriatic Arthritis: Does Family History Influence the Time to Onset of Arthritis in Psoriasis Patients?
- 10:30AM-12:30PM
-
Abstract Number: 0543
Unveiling Sacroiliac Joint Involvement in Psoriatic Arthritis: MRI, Radiographic, and Clinical Insights from 581 European Routine Care Patients